Healthcare
Live Price
Offline$40.50
+0.00% today
1Y Change
+210.58%
Window
Jun 26, 2025 → Jun 25, 2026
Coverage: 250 bars · Jun 26, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Centessa Pharmaceuticals plc American Depositary Receipt (CNTA) is a Healthcare stock with a market cap of $5.92B and listed on NASDAQ. The stock last traded around $40.50 and up 210.6% across the available one-year price window (Jun 26, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +29.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +29.1%, free cash flow -36.7% with operating margin 0.0% and ROIC -42.4%. Stock Foundry combines CNTA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CNTA
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CNTA Max Drawdown
-26.38%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CNTA and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.